Pulmonary function in Pi M and MZ grainworkers.

Twenty-eight men with the Pi MZ phenotype who have been employed in the Saskatchewan country grain elevators and thus regularly exposed to high levels of grain dust, were case matched for age, years of employment, employment status, smoking status, and smoking history with grainworkers of type Pi M. Individuals answered a questionnaire, had a chest roentgenogram, skin tests, and performed a battery of pulmonary function tests. There were no differences between the two groups in prevalence of symptoms or atopy. Although not statistically significant, the MZ group had three times as many individuals with abnormal roentgenograms suggestive of COPD as the M group. The Pi MZ grainworkers had consistently poorer mean results for the pulmonary function tests with significantly lower mean values for FEV1, FEV1/FVC, MMFR, and Vmax50, leading us to suggest that Pi MZ individuals may be at higher risk of COPD than Pi M individuals, but only in the presence of other risk factors such as grain dust exposure.

[1]  B. Cohen,et al.  Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects. , 2015, The American review of respiratory disease.

[2]  A. Lovegrove,et al.  Pi type MZ and an increased risk of pneumonia. , 1984, Clinical and investigative medicine. Medecine clinique et experimentale.

[3]  Cockcroft Dw,et al.  Measurement of responsiveness to inhaled histamine: comparison of FEV1 and SGaw , 1983 .

[4]  F. Kauffmann,et al.  Genetic markers in chronic air-flow limitation. A genetic epidemiologic study. , 1983, The American review of respiratory disease.

[5]  D. Cotton,et al.  Effects of grain dust exposure and smoking on respiratory symptoms and lung function. , 1983, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[6]  T. Meade,et al.  ABH secretor status and pulmonary function. , 1982, American journal of epidemiology.

[7]  B. Cohen,et al.  Chronic obstructive pulmonary disease: a challenge in genetic epidemiology. , 1980, American journal of epidemiology.

[8]  G. Beckman,et al.  Alpha-1-antitrypsin types and chronic obstructive lung disease in an industrial community in Northern Sweden. , 1980, Human heredity.

[9]  A. Gulsvik,et al.  Alpha 1-antitrypsin phenotypes and obstructive lung disease in the city of Oslo. , 1979, Scandinavian journal of respiratory diseases.

[10]  C. Mittman.  The PiMZ phenotype: is it a significant risk factor for the development of chronic obstructive lung disease? , 2015, The American review of respiratory disease.

[11]  J. Schoenberg,et al.  Growth and decay of pulmonary function in healthy blacks and whites. , 1978, Respiration physiology.

[12]  D. McGee,et al.  Intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease in Yugoslavia. , 1978, The American review of respiratory disease.

[13]  C. Larsson,et al.  Smoking and intermediate alpha1-antitrypsin deficiency and lung function in middle-aged men. , 1977, British medical journal.

[14]  G. S. Mudholkar,et al.  The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease. , 1976, The American review of respiratory disease.

[15]  V. Hoeppner,et al.  Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy. , 1976, The American review of respiratory disease.

[16]  N. Nevin,et al.  Relation of alpha-1-antitrypsin phenotype to the performance of pulmonary function tests and to the prevalence of respiratory illness in a working population. , 1976, Thorax.

[17]  P. Macklem,et al.  The Use of a Helium-Oxygen Mixture during Maximum Expiratory Flow to Demonstrate Obstruction in Small Airways in Smokers. , 1975, The Journal of clinical investigation.

[18]  M. Lebowitz,et al.  A community study of the relation of alpha1-antitrypsin levels to obstructive lung diseases. , 1975, The New England journal of medicine.

[19]  A. C. Bryan,et al.  Lung function in alpha1-antitrypsin heterozygotes (Pi type MZ). , 2015, The American review of respiratory disease.

[20]  H. Toutenburg.  Fleiss, J. L.: Statistical Methods for Rates and Proportions. John Wiley & Sons, New York‐London‐Sydney‐Toronto 1973. XIII, 233 S. , 1974 .

[21]  Buist As,et al.  Quantitative analysis of the alveolar plateau in the diagnosis of early airway obstruction. , 1973 .

[22]  D. Webb,et al.  Serum alpha 1-antitrypsin variants. Prevalence and clinical spirometry. , 1973, The American review of respiratory disease.

[23]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[24]  R. Kanner,et al.  Pathologic patterns of chronic obstructive pulmonary diseases in patients with normal and deficient levels of alpha 1 antitrypsin. , 1973, The American journal of medicine.

[25]  B. Garoutte,et al.  Identification and characteristics of the common alpha 1 -antitrypsin phenotypes. , 1972, Chest.

[26]  J. Morris,et al.  Spirometric standards for healthy nonsmoking adults. , 2015, The American review of respiratory disease.

[27]  J. Mead,et al.  IMPROVED TECHNIQUE FOR ESTIMATING PLEURAL PRESSURE FROM ESOPHAGEAL BALLOONS. , 1964, Journal of applied physiology.

[28]  Goldman Hi,et al.  Respiratory function tests; normal values at median altitudes and the prediction of normal results. , 1959 .